Peer Mentoring for Type 1 Diabetes
(Glu-COACH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using a continuous glucose monitoring device for diabetes management.
Is the Dexcom G6 Continuous Glucose Monitoring System safe for use in humans?
How is the Glu-COACH treatment for Type 1 Diabetes different from other treatments?
The Glu-COACH treatment, using the Dexcom G6 Continuous Glucose Monitoring System, is unique because it provides real-time glucose monitoring, which helps patients manage their blood sugar levels more effectively and can lead to improved quality of life and reduced diabetes-related stress. Unlike traditional methods, it offers features like alerts for high or low blood sugar and remote data sharing, which can enhance patient engagement and glycemic control.12567
What data supports the effectiveness of the treatment Enhanced standard-of-care (ESOC), Dexcom G6, Dexcom G6 Continuous Glucose Monitoring System, Glu-COACH, Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 CGM System for Type 1 Diabetes?
Research shows that using the Dexcom G6 Continuous Glucose Monitoring System can significantly lower HbA1c levels (a measure of blood sugar control) and improve quality of life for people with diabetes. Most users reported high satisfaction and ease of use, indicating that the system is effective and user-friendly.12358
Who Is on the Research Team?
Robin Whittemore, PhD, APRN, FAAN
Principal Investigator
Yale School of Nursing
Stuart A Weinzimer, MD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for Black and Latinx adolescents with type 1 diabetes who may benefit from using a continuous glucose monitor (CGM) to manage their condition. The study aims to help those who have not started or are struggling to maintain the use of CGM.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either enhanced standard-of-care (ESOC) or Glu-COACH intervention, which includes peer-mentoring support and access to a private social media group
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, 3 months, and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced standard-of-care (ESOC)
- Glu-COACH
Enhanced standard-of-care (ESOC) is already approved in United States for the following indications:
- Management of diabetes in persons age 2 years and older
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator